Search results

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

Advanced Clinical is a privately held clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of those touched by clinical research and help our clients get better outcomes.

Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.

Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target scalable low COGS products, based on genetically engineered lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers - Cancers - Ovarian, Peritoneal

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

Catalent is the global leader in enabling pharma, cell & gene therapy and biopharma partners to optimize product development, launch, and full life-cycle supply for patients around the world. Catalent helps accelerate over 1,000 partner programs every year for partners of all sizes.

Centenara is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan. We provide start-up coaching and funding to entrepreneurial scientists to co-create therapies that benefit our aging population.

You are planning your first trial and need to build up a ClinOps team? You would like your trial to run more efficiently? Do you need support to prepare for an inspection or develop SOPs? You will find the collaboration with us useful to obtain advice and create a strategy for long-term success.

Cure Pharma specializes in clinical supply management, including global supply chain coordination, comparator sourcing, logistics, and innovative labelling solutions. With a strong network and regulatory expertise, we ensure efficient, compliant, and reliable supply solutions for clinical studies.

ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing Advanced Therapies. Our next generation CDMO model enables an attractive pricing structure and expertise in CMC for speed to Phase I/IIa.

HBM Partners is a Swiss healthcare investor with over $2.5 billion assets under management. HBM Partners was founded in 2001 with the goal to invest in emerging private and public biopharma and other healthcare companies. HBM Partners is regulated by FINMA and manages SIX listed HBM Healthcare Investments (ww

Health Advances is a strategy consulting firm that focuses exclusively on the healthcare industry. We are scientists, clinicians, and business professionals who share a passion for supporting commercialization and driving adoption of innovations that improve healthcare.

ICE Biopharma has 2 core businesses: in-licensing specialty and rare disease drugs for Europe and Canada, and operational consultancy to companies evaluating international Commercialization options. We want European and Canadian patients to have access to the breakthrough therapies they deserve.

Based on the liposomal technology platform, InnoMedica has built a diversified pipeline with lead compounds in oncology and neurodegenerative diseases. Clinical trials for the treatment of breast cancer as well as Parkinson's disease are conducted in Swiss hospitals.

IQVIA integrates clinical and commercial expertise to deliver flexible solutions tailored for biotech companies. Work with IQVIA, the global leader in clinical development, Real World Evidence, and the commercialization of new treatments to deliver a winning asset at launch and beyond.

Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.

Toxicology Consultant with >25 years of experience in the Biopharmaceutical Industry. I support Startup and Biotech Companies to advance their projects into the clinical phase. Get in touch to discuss your project when you have a shortage of nonclinical and toxicological expertise.

We build true longevity by turning proven drugs into patient-friendly, affordable prescription medicines. With our ORASMART® platform technology, we scale from an initial focus on two indications to more than 30 longevity therapies across metabolic diseases, chronic care, and beyond.

PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.

Rambam AG is a Swiss-based venture studio and accelerator platform for breakthrough drug discovery and development. Our portfolio of companies and programs is supported by a core group of seasoned industrial experts, PMs and dedicated functional experts from Switzerland, Portugal, Germany and the US.

Remap Consulting is a specialist pharmaceutical pricing and market access consultancy. We help people to determine the optimal price for their product, the right evidence to support pricing & market access at launch, the right training capabilities to secure pricing and reimbursement.

SGS M-Scan is a world leading GLP/cGMP contract analytical services group dedicated to providing high quality analysis of biopharmaceuticals. Studies involve molecules at all stages of product development.

Stallergenes Greer is a fully integrated global healthcare company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.

Headquartered in Zug, Switzerland, Swizzard Pharma AG's mission is to support pharma/biotech companies in setting up a smart & lean Swiss infrastructure. We build on long-term partnership and offer a quality approach to maximize the value of your medical breakthroughs in Switzerland.

Founded in mid-2022, T-Oncology is a Swiss biotech startup dedicated to transforming cancer treatment through innovative therapies. Our Mission: Give hope to patients by creating advanced therapeutics that offer safe and more effective treatment options, affordable for patients worldwide.

Provides consulting services to pharma and biotech clients in market access and pricing area. Support geographic expansion strategies for Asian life sciences companies. Trading in nutraceuticals products for European markets.

Life Technologies Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community.

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

Wemedoo AG is a clinical information specialist who specializes in the development of clinical data information systems, as well as data collection, management, analysis, and reporting. We transform healthcare by seamlessly unifying clinical research and clinical practice.

Xcube.bio invests capital, knowledge and capabilities in the European market entry of late-stage biopharmas, with the objective to create partners' own commercial footprint and revenue streams. We offer a unique value proposition that open and de-risk the European market for innovative therapies.